PARP inhibitor Talazoparib recommended by NICE for the treatment of hereditary BRCA mutated metastatic breast cancer

METUPUK are delighted by the National Institute of Clinical Excellence (NICE) decision to recommend Talazoparib (Talzenna ®, Pfizer Ltd.) for treating HER2-negative, locally advanced or metastatic breast cancer with germline

China Doll

Birthday and cancerversaries became bittersweet as I was dealing with the realities of cancer, the side effects, the constant fear of the unknown, the helplessness, the indignity of losing who you are, who you were, even things you take for granted like walking up your own stairs or getting out the bath (because the treatment has made you weak).

And so, I feel with every year I am living with MBC, with every new treatment and with every progression, I am like a china doll. Leaving broken pieces of me behind.  

Philippa Hetherington Remembered

We had to confirm back on the 5th November the heartbreaking news that the wonderful Philippa Hetherington had died 💔

She was an absolute force of intellectual nature for breast cancer in general, not just Inflammatory Breast Cancer.

Did you know that the Trodelvy campaign in England for TNBC was HER campaign?